Stockscreener 앱 받기
10.70
0.28%
0.03
시장 영업 전:
10.71
0.01
+0.09%
전일 마감가:
$10.67
열려 있는:
$10.72
하루 거래량:
149.59K
Relative Volume:
0.43
시가총액:
$187.82M
수익:
$1.54M
순이익/손실:
$-38.70M
주가수익비율:
-2.2912
EPS:
-4.67
순현금흐름:
$-36.86M
1주 성능:
-9.93%
1개월 성능:
-4.89%
6개월 성능:
+26.33%
1년 성능:
-33.33%
1일 변동 폭
$10.50
$10.82
1주일 범위
$10.05
$11.98
52주 변동 폭
$4.64
$20.56
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
명칭
Corbus Pharmaceuticals Holdings Inc
전화
617-963-0103
주소
500 RIVER RIDGE DRIVE, NORWOOD, MA
CRBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
10.70 | 187.29M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2025-02-28 | 개시 | William Blair | Outperform |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 개시 | Wedbush | Outperform |
| 2024-07-22 | 재개 | H.C. Wainwright | Buy |
| 2024-06-26 | 개시 | B. Riley Securities | Buy |
| 2024-06-03 | 재확인 | Oppenheimer | Outperform |
| 2024-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-07 | 개시 | ROTH Capital | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-03-26 | 개시 | Nomura | Buy |
| 2019-04-05 | 개시 | Jefferies | Buy |
| 2019-03-20 | 개시 | Oppenheimer | Outperform |
| 2019-01-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-12-26 | 개시 | H.C. Wainwright | Buy |
| 2018-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2018-10-24 | 개시 | B. Riley FBR | Buy |
| 2018-01-19 | 개시 | Raymond James | Outperform |
| 2017-12-14 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-11-08 | 재확인 | Noble Financial | Buy |
| 2017-09-29 | 재개 | Noble Financial | Buy |
| 2017-03-30 | 재확인 | Cantor Fitzgerald | Overweight |
| 2016-11-15 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-11-11 | 재확인 | Noble Financial | Buy |
모두보기
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock attracts wealthy investorsEntry Point & Advanced Technical Signal Analysis - Newser
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock trades below fair value2025 Volume Leaders & High Conviction Investment Ideas - Newser
What risks investors should watch in Corbus Pharmaceuticals Holdings Inc. stock2025 AllTime Highs & Intraday High Probability Alerts - Newser
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidate2025 Big Picture & Real-Time Volume Surge Alerts - Newser
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock bottoming after sell offStop Loss & Free Weekly Watchlist of Top Performers - Newser
Behavioral Patterns of CRBP and Institutional Flows - news.stocktradersdaily.com
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock could be top winnerForecast Cut & AI Driven Stock Movement Reports - Newser
Will Corbus Pharmaceuticals Holdings Inc. stock remain a Wall Street favoriteInsider Buying & Technical Confirmation Trade Alerts - Newser
B. Riley Forecasts Lower Earnings for Corbus Pharmaceuticals - MarketBeat
What analysts say about Corbus Pharmaceuticals Holdings Inc 3371 stockSector Performance Drivers & Free Trading Psychology Sessions - earlytimes.in
What is B. Riley’s Forecast for CRBP FY2029 Earnings? - Defense World
(CRBP) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
How interest rate cuts could boost Corbus Pharmaceuticals Holdings Inc. stockPortfolio Performance Summary & Free Long-Term Investment Growth Plans - newser.com
Cannabis Pharmaceuticals Market | Global Market Analysis Report2035 - Fact.MR
Can Corbus Pharmaceuticals Holdings Inc. (3371) stock sustain margin levelsWeekly Gains Summary & High Return Trade Opportunity Guides - newser.com
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top hedge fund pickEarnings Beat & AI Enhanced Trading Signals - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock surprise with earnings upside2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
What analyst consensus says on Corbus Pharmaceuticals Holdings Inc. stock2025 Technical Overview & Fast Momentum Stock Entry Tips - newser.com
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
How hedge fund analytics apply to Corbus Pharmaceuticals Holdings Inc. stockForecast Cut & Daily Risk Controlled Trade Plans - newser.com
Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.Quarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock attracts global investors2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a fit for income portfoliosJuly 2025 Reactions & Safe Capital Growth Plans - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock attracts high net worth investors2025 Dividend Review & Long-Term Growth Portfolio Plans - newser.com
Understanding Corbus Pharmaceuticals Holdings Inc.’s price movementEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Corbus Pharmaceuticals Holdings Inc (3371.BE) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarPrice Action & Weekly Market Pulse Alerts - newser.com
Corbus Pharmaceuticals Holdings Inc (CRBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):